Drug delivery to lymphatic tissue

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 13, Issue 1-2, 1996, Pages 57-84

  Papisov, Mikhail ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AIDS; cancer; colloid; drug carrier; drug delivery; lymph; lymph node; lymphography; macromolecule; metastasis; targeting

Indexed keywords

8 QUINOLINOL INDIUM IN 111; COPOLYMER; DEXTRAN DERIVATIVE; DRUG CARRIER; GALLIUM CITRATE; METALLOPORPHYRIN; MION 37; MION 46; PGM S05; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

CANCER LOCALIZATION; COLLOID; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG TARGETING; DRUG TRANSPORT; INTRAARTERIAL DRUG ADMINISTRATION; INTRALYMPHATIC DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPH FLOW; LYMPH NODE; LYMPHOID TISSUE; MACROMOLECULE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PHARMACOKINETICS; REGIONAL PERFUSION; REVIEW;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODY SPECIFICITY; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; INJECTIONS, INTRAVENOUS; LYMPH NODES; LYMPHATIC DISEASES; MOLECULAR WEIGHT; T-LYMPHOCYTES; TISSUE DISTRIBUTION;

EID: 0029743065     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (157)

1. Weiss, L., The pathophysiology of metastasis within the lymphatic system, in Lymphatic System Metastases, Weiss L., Gilbert, H., Ballon, S., Eds., Hall, Boston, 2, 1988.
2. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Terner-Racz, K., Haase, A. T., Massive covert infection of T-lymphocytes and macrophages by HIV during the incubation period of AIDS, Nature, 362, 359, 1993.
3. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., Fauci, A. S., HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease, Nature, 362, 355, 1993.
4. Drutz, D. J., The Mycoses, in Cecil Textbook of Medicine, Wyngaarden, J. B., Smith, L. H., Eds., W. B. Saunders, Philadelphia, 1985.
5. Wolinsky, E., Tuberculosis, in Cecil Textbook of Medicine, Wyngaarden, J. B., Smith, L. H., Eds., W. B. Saunders, Philadelphia, 1985.
6. Som, P., Lymph nodes of the neck, Radiology, 165, 593, 1987.
7. De Sousa, M., Lymphocyte circulation, John Wiley & Sons, New York, 1981.
8. Charman, W. N., Stella, V. J., Eds., Lymphatic Transport of Drugs, CRC Press, Boca Raton, FL, 1992
9. Yoffey, J. and Courtice, F., Lymphatics, lymph, and the lymphomyeloid complex. Academic Press, London, 1970.
10. Rhodin, J., Histology, A text and atlas, Oxford University Press, New York, 1974.
11. Ioachim, H., The normal lymph node, in Lymph node biopsy, Ioachim, H., Ed., J. B. Lippincott Company, Philadelphia, 3, 177, 373, 1980.
12. Robb-Smith, A. and Taylor, C., The human lymph node, in Lymph node biopsy, Robb-Smith, A. and Taylor, C., Eds., Oxford University Press, New York, 9, 1981.
13. Cottier, H., Odartchenko, N., Schindler, R., and Congdon, C. C., Eds., Germinal centers in immune responses, Springer-Verlag, Berlin, 1967.
14. Fossum, S., Ford, W. L., The organization of cell populations within lymph nodes: their origin, life history, and functional relationships, Histopathology, 9, 469, 1985.
15. Fossum, S., The architecture of rat lymph nodes. II. Lymph node Compartments, Scand. J. Immunol., 12, 411, 1980.
16. Wiederheilm, C., The interstitial space and lymphatic pressures in the bat wing, in The pulmonary circulation and interstitial space, Fisman, P. and Hecht, H., Eds., University of Chicago Press, Chicago, IL, 1969.
17. Barrowman, J., Physiology of the gastrointestinal lymphatic system, Cambridge University Press, Cambridge, 1978.
18. Yoffey, J. and Courtice, F., Lymphatics, lymph, and the lymphomyeloid complex, Academic Press, London, 171, 1970.
19. Schnitzer, J. E., gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis, Am. J. Physiol., 262, H246, 1992.
20. Clementi, L. and Palade, G., Intestinal capillaries. I. Permeability to peroxidase and ferritin, J. Cell Biol., 41, 33, 1969.
21. Majno, G. and Joris, I., Endothelium 1977: A review, Adv. Exp. Med. Biol., 104, 169, 1978.
22. Mayerson, H. S., Wolfram, C. G., Shirley, H. H., Wasserman, K., Regional differences in capillary permeability. Am. J. Physiol., 198(I), 155, 1960.
23. Simionescu, M., Ghitescu, L., Fixman, A., and Simionescu, N., How plasma macromolecules cross the endothelium, NIPS, 2, 97, 1987.
24. Palade, G., Simionescu, M., and Simionescu, N., Structural aspects of the permeability of the microvascular endothelium, Acta Physiol. Scand., 463 (Suppl), 11, 1979.
25. Bruns, R. and Palade, G., Studies on blood capillaries, I. General organization of blood capillaries in muscle, J. Cell Biol., 37, 244, 1968; Studies on blood capillaries, II. Transport of ferritin molecules across the wall of muscle capillaries, J. Cell Biol., 37, 277, 1968.
26. Bruns, R. and Palade, G., Studies on blood capillaries, I. General organization of blood capillaries in muscle, J. Cell Biol., 37, 244, 1968; Studies on blood capillaries, II. Transport of ferritin molecules across the wall of muscle capillaries, J. Cell Biol., 37, 277, 1968.
27. Porter, G. and Bankston, P., Functional Maturation of the capillary wall in the fetal and neonatal rat heart: Permeability characteristics of developing myocardial capillaries, Am. J. Anat., 180, 323, 1987.
28. Simionescu, M., Simionescu, N., and Palade, G., Biochemically differentiated microdomains of the cell surface of capillary endothelium, Ann. NY Acad. Sci., 401, 9, 1982.
29. Milici, A. and Bankston, P., Fetal and neonatal rat intestinal capillaries: permeability to carbon, ferritin, hemoglobin, and myoglobin, Am. J. Anat., 165, 165, 1982.
30. Porter, G. A. and Bankston, P. W., Maturation of myocardial capillaries in the fetal and neonatal rat: An ultrastructural study with a morphometric analysis of the vesicle populations, Am. J. Anat., 178, 116, 1987.
31. Boyd, R. D. H., Hill, J. R., Humphreys, P. V., Normand, I. C. S., Reynolds, E. O. R., and Strang, L. B., Permeability of lung capillaries to macromolecules in foetal and new-born lambs and sheep, J. Physiol., 201, 567, 1968.
32. Schnitzer, J. E., gp60 is an albumin-binding glycoprotein expresed by continuous endothelium involved in albumin transcytosis, Am. J. Physiol., 262, H246, 1992.
33. Frank, M. M., and Fries, L. F., The role of complement in inflammation and phagocytosis, Immunol. Today, 12, 322, 1991.
34. Fujita, S., Puri, R., Yu, Z.-X., Travis, W., Ferrans, V., An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2, Cancer, 68, 2169, 1991.
35. Royall, J. A., Berkow, R. L., Beckman, J. S., Cunningham, M. K., Matalon, S., and Freemen, B. A., Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability, Am. J. Physiol., 257, L399, 1989.
36. Barrowman, J., Physiology of the gastrointestinal lymphatic system, Cambridge University Press, Cambridge, 1978.
37. Wiederheilm, C., The interstitial space and lymphatic pressures in the bat wing, in The pulmonary circulation and interstitial space, Fisman, P. and Hecht, H., Eds., University of Chicago Press, Chicago, 1969.
38. Leak, L., Studies on the permeability of lymphatic capillaries, J. Cell Biol., 50, 300, 1971.
39. Johanssen, B., Capillary permeability to interstitial microinjections of macromolecules and influence of capillary hydrostatic pressure on endothelial ultrastructure, Acta Physiol. Scand., 463 (Suppl), 45, 1979.
40. Adair, T. and Guyton, A., Physiology - lymph formation, its control, and lymph flow, in Lymphatic imaging. Lyniphography, CT, and Scintigraphy, Clouse, M. and Wallace, S., Eds., Williams and Wilkins, Baltimore, MD, 120, 1987.
41. Nordmann, M., Studien Lymphknoten bei akuten und chronischen Allgemeininfectionen, Virchovs Arch. Path. Anat. Physiol., 267, 158, 1928.
42. Ercan, M. T., and Kriegel, H., Autoradiography of Lymph nodes with 99mTc dextran in rabbits, Nucl. Med. Biol., 19, 101, 1992.
43. Fisher, B., Fisher, E., Transmigration of Lymph nodes by tumor cells, Science, 152, 1397, 1966.
44. Yoffey, J. and Courtice, F., Lymphatics, lymph and the lymphomyeloid complex, Academic Press, London, 1970.
45. Fisher, B. and Fisher, E., Barrier function of lymph node to tumor cells and erythrocytes, I. Effect of x-ray, inflammation, sensitization and tumor growth, Cancer, 20, 1914, 1967.
46. Anderson, A. and Anderson, N., Studies on the structure and permeability of the microvasculature in normal rat lymph nodes, Am. J. Pathol., 80, 387, 1975.
47. Bevilacqua, M. P., Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol., 11, 767, 1993.
48. Stoolman L. M., Adhesion molecules controlling lymphocyte migration, Cell, 65, 907, 1989.
49. Farr, A. and De Bruyn, P., The mode of lymphocyte migration through postcapillary venule endothelium in lymph node, Am. J. Anat., 143, 59, 1975.
50. DeSousa, M., Lymphocyte circulation, John Wiley & Sons, New York, 7, 1981.
51. VanDeurs, B., Röpke, C., and Westergaard, E., Permeability properties of the postcapillary high-endothelial venules in lymph nodes of the mouse, Lab Invest., 32, 201, 1975.
52. Mikata, A. and Niki, R., Permeability of postcapillary venules of the lymph node. An electron microscopic study, Exp. Mol. Pathol., 14, 289, 1971.
53. Nopajaroonsri, C., Luk, S., and Simon, G., The passage of intraveneously injected colloidal carbon into lymph node parenchyma, Lab Invest., 30, 533, 1974.
54. Ohtake, E. and Matsui, K., Lymphoscintigraphy in patients with lymphedema. A new approach using intradermal injections of technetium-99m human serum albumin, Clin. Nucl. Med., 11, 474, 1986.
55. Ljungstrom, K. G., Willman, B., and Hedin, H., Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveilance of dextran 1. Ann. Fr. Anesth. Reanim., 12, 219, 1993.
56. Magro, A. M., Histamine release from fawn-hooded rat mast cells is not potentiated by phosphatidylserine, Immunology, 44, 1, 1981.
57. Blazo, G., Koltai, M., Ottlecz, A., Minker, E., Dextran anaphylactoid reaction in Sprague-Dawley CFY rats, Acta Physiol. Acad. Sci. Hung., 54, 281, 1979.
58. Warne, P. J. and West, G. B., Seasonal variation in drug action and animal responses in models of inflammation, Int. Arch. Allergy Appl. Immunol., 61, 111, 1980,
59. Hanahoe, T. H. and Wright, J. D., Distribution of 3H-dextran in two colonies of Wistar rats after intravenous injection, Int. Arch. Allergy Appl. Immunol., 72, 366, 1983.
60. Kinmouth, J., Taylor, G., and Harper, R., Lymphaniography: A technique for its clinical use in the lower limb, BMJ, 940, 1955.
61. Morehouse, H. and Thornhill, B., Nodes or no nodes: CT of adenopathy, Crit. Rev. Diagn. Imaging, 25, 177, 1986.
62. Ballard, B. E., Biopharmaceutical considerations in subcutaneous and intramuscular drug administration, J. Pharm. Sci., 57, 357, 1968.
63. Schreuders, P. D., Diller, K. R., Beaman, Jr., J. J., and Paynter, H. M., An analysis of coupled multicomponent diffusion in interstitial tissue, J. Biomech. Eng., 116, 164, 1994.
64. Cole, W. C., LeBlanc, A. D., and Jhingran, S. G., The origin of biexponential T2 relaxation in muscle water, Magn. Res. Med., 29, 19, 1993.
65. Kim, D., Armenante, P. M., and Duran, W. N., Mathematical modeling of mass transfer in microvascular wall and interstitial space, Microvasc. Res., 40, 358, 1990.
66. Sung, C., Shockley, T. R., Morrison, P. F., Dvorak, H. F., Yarmush, M. L., and Dedrick, R. L., Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors, Cancer Res., 52, 377, 1992.
67. Cassidy, J., Newell, D. R., Wedge, S. R., and Cummings, J., Pharmacokinetics of high molecular weight agents, Cancer Surv., 17, 315, 1993.
68. Winchell, H. S., Mechanisms for localization of radiopharmaceuticals in neoplasms, Sem. Nuc. Med., 6, 371, 1976.
69. Henze E., Schelbert H. R., Collins J. D., Najafi, A., Barrio, J. R., and Bennet, L. R., Lymphoscintigraphy with Tc-99m-labeled dextran, J. Nucl. Med., 23, 923, 1982.
70. Harika, L., Weissleder, R., Zimmer, C., Poss, K., Papisov, M., and Brady, T. J., MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM, Magn. Res. Med., 33, 88, 1995.
71. Torchilin, V. P., Trubetskoy, V. S., Milshtein, A. M., Canillo, J., Wolf, J., Papisov, M. I., Bogdanov, A. A., Narula, J., Khaw, B. A., and Omelyanenko, V., Targeted delivery of diagnostic agents by surface-modified liposomes, J. Control. Rel., 28, 45, 1994.
72. Moghimi, S. M., Hawley, A. E., Christy, N. M., Gray, T., Illum, L., and Davis, S. S.,Surface-engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes, FEBS Lett., 344, 25, 1994.
73. Croll, M., Brady, L. and Daparvar, S., Implications of lymphoscintigraphy in oncologic practice: Principles and differences vis-a-vis other imaging modalities, Sem. Nucl. Med., 13(1), 4, 1983.
74. Ege, G., Radiocolloid lymphoscintigraphy in neoplastic disease, Cancer Res., 40, 3065, 1980.
75. Ege, G. and Cummings, B., Interstitial radiocolloid iliopelvic lymphoscintigraphy: technique, anatomy, and clinical application, Int. J. Rad. Oncol. Biol. Phys., 6, 1483, 1980.
76. Kaplan, W., Iliopelvic lymphoscintigraphy, Sem. Nuc. Med., 13(1), 42, 1983.
77. Henze E., Schelbert H. R., Collins J. D., Najafi, A., Barrio, J. R., and Bennet, L. R., Lymphoscintigraphy with Tc-99m-labeled dextran, J. Nucl. Med., 23, 923, 1982.
78. Strand, S., Andersson, L., and Bergqvist, L., Applications and characterization of radiolabelled or magnetizable nano- and microparticles for RES, lymph, and blood flow studies, in Microspheres: medical and biological applications, Rosenbaum, A. and Tokes, Z., Eds., CRC Press, Boca Raton, FL, 194, 1988.
79. Weissleder, H. and Weissleder, R., Lymphedema: Evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients, Radiology, 167, 729, 1988.
80. Weinstein, J. N., Eger, R. R., Covell, D. G., Black, C. D., Mulshine, J., Carrasquillo, J. A., Larson, S. M., and Keenan, A. M., The pharmacology of monoclonal antibodies, Ann. NY Acad. Sci., 507, 199, 1987.
81. Dooms, G., Hricak, H., Moseley, M., Bottles, K., Fisher, M., and Higgins, C., Characterization of lymphadenopathy by magnetic resonance relaxation times: Preliminary Results, Radiology, 155, 691, 1985.
82. Buckwalter, K., Ellis, J., Baker, D., Borello, J., and Glazer, G., Pitfall in MR imaging of lymphadenopathy after lymphangiography, Radiology, 161, 831, 1986.
83. Glazer, G., Orringer, M., Chenevert, T., Borrello, J., Penner, M., Quint, L., Li, K., and Aisen, A., Mediastinal lymph nodes: Relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging, Radiology, 168, 429, 1988.
84. Fossel, E., Brodsky, G., DeLayre, J., and Wislon, R., Nuclear magnetic resonance for the differentiation of benign and malignant breast tissues and axillary lymph nodes, Ann. Surg., 198, 541, 1983.
85. Wiener, J., Chako, A., Merten, C., Gross, S., Coffey, E., and Stein, H., Breast and axillary tissue MR imaging: Correlation of signal intensities and relaxation times with pathologic findings, Radiology, 160, 299, 1986.
86. Weissleder, R., Elizondo, G., Josephson, L., Compton, C. C., Fretz C. J., Stark, D. D., and Ferrucci, J. T., Experimental lymph node metastases: enhanced detection with MR lymphography, Radiology, 171, 835, 1989.
87. Weissleder, R., unpublished observations.
88. Lee, A. S., Weissleder, R., Wittenberg, J., and Brady, T. J., Lymph nodes: microstructural anatomy at MR imaging, Radiology, 178, 519, 1991.
89. Takakura, Y., Matsumoto, S., Hashida, M., and Sezaki, H., Enhanced lymphatic delivery of mitomycin C conjugated with dextran, Cancer Res., 44, 2505, 1984.
90. Takakura, Y., Hashida, M., and Sezaki, H., Lymphatic transport after parenteral drug administration, in Lymphatic Transport of Drugs, Charman, W. N. and Stella, V. J., Eds., CRC Press, Boca Raton, FL, 1992, 255.
91. Charman, W., Lipid vehicle and formulation effects on intestinal lymphatic drug transport, in Lymphatic Transport of Drugs, Charman, W. N. and Stella, V. J., Eds., CRC Press, Boca Raton, FL, 113, 1992.
92. Yoshikawa, H. and Muranishi, S., Lymphatic transport of polar drugs after gastrointestinal administration, in Lymphatic Transport of Drugs, Charman, W. N. and Stella, V. J., Eds., CRC Press, Boca Raton, FL, 1992, 233.
93. Thoren-Tolling K. and Jonsson L., Cellular distribution of orally and intramuscularly administered iron dextran in newborn piglets, Can. J. Comp. Med., 41, 318, 1977.
94. Brondsted, H. and Kopecek, J., Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation, Pharm. Res., 9, 1540, 1992.
95. Sulfaro, S., Frustaci, S., Volpe, R., Barzan, L., Comoretto, R., Monfardini, S., and Carbone, A., A pathologic assessment of tumor residue and stromal changes after intra-arterial chemotherapy for head and neck carcinomas. A study on serial sections of the whole surgical specimen, Cancer, 64, 994, 1989.
96. Takeuchi, K., Taniguchi, H., Miyata, K., Koyama, H., Tanaka, H., Ueshima, Y., Okano, S., Oguro, A., Itoh, A., and Sawai, K., Recurrence and survival rate of advanced gastric cancer after preoperative intraarterial EAP I injection therapy (Japanese), Gan to Kagaku Ryoho, 20, 1654, 1993.
97. Takatsuka, Y., Sugitachi, A., Morimoto, K., Sakamoto, I., and Kawahara, T., Transcatheter arterial chemo-embolization (TAC-E) for patients with locally advanced breast cancer, Jap. J. Clin. Oncol., 15, 107, 1985.
98. DeMeester, T., Beckerman, C., Joseph, J., Toscano, M. S., Golomb, H., Bitran, J., Gross, N. J., and Skinner, D. B., Gallium 67 scanning for carcinoma of the lung, J. Thorac. Cardiovasc. Surg., 72, 699, 1976.
99. Fawwaz, R., Hemphill, W., and Winchel, H., Potential use of 109Pd-porphyrin complex for selective lymphatic ablation, J. Nuc. Med., 12, 231, 1971.
100. Robinson, Jr., G. D., Alavo, A., Vaum, R., and Staum, M., Imaging of lymph node uptake after intravenous administration, J. Nucl. Med., 27, 239, 1986.
101. Patronas, N. J., Cohen, J. S., Knop, R. H., Dwyer, A. J., Colcher, D., Lundy, J., Mornex, F., Hambright, P., Sohn, M., and Myers, C. E., Metalloporphyrin contrast agents for magnetic resonance imaging of human tumars in mice, Cancer Treat. Rep., 70, 391, 1986.
102. Figge, F., Weiland, G., and Manganiello, L., Cancer detection and therapy. Affinity of neoplastic, embryonic and traumatized tissues for porphyrins and metalloporphyrins, Proc. Soc. Exp. Biol. Med., 68, 640, 1984.
103. Fawwaz, R. A., Oluwole, S., Wang, T. S., Kuromoto, N., Iga, C., Hardy, M. A., and Alderson, P. O., Biodistribution of radiolabeled lymphocytes, Radiology, 155, 483, 1985.
104. ten Berge, R. J. M., Natarajan, A. T., Hardeman, M. R., van Royen, E. A., and Schellekerts, P. Th. A., Labeling with indium-111 has detrimental effects on human lymphocytes: Concise communication, J. Nuc. Med., 24, 615, 1983.
105. Tsai, E., Bogdanov, A. A., Papisov, M. I., Brady, T. J., and Weissleder, R., Lymphocytes as drug carriers for MR contrast agents, in Proceedings of Eleventh Annual Meeting of the Society of Magnetic Resonance in Medicine, SMRM, Berkeley, CA, 862, 1992.
106. Yeh, T., Zhang, W., Ilstad, S. T., and Ho, C., MR cell tracking in rats of T cells labeled with superparamagnetic iron-oxide particles, in Proceedings, Society of Magnetic Resonance Second Meeting, SMRN, Berkeley, CA, 1994.
107. De Jager, R., Abdel-Nabi, H., Serafini, A., Pecking, A., Klein, J. L., and Hanna, Jr., M. G., Current status of cancer immunodetection with radiolabeled human monoclonal antibodies, Sem. Nuc. Med., 23, 165, 1993.
108. Baum, R. P., Niesen, A., Hertel, A., Adams, S., Kojouharoff, G., Goldenberg, D. M., and Hor, G., Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B cell lymphomas, Cancer, 73 (3 Suppl), 896, 1994.
109. Larson, S. M., Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture, Radiology, 165, 297, 1987.
110. Capon, D. J. and Lasky, L. A., Hybrid immunoglobulins, US Patent 5116964, 1992; Lymphocyte homing receptor/immunoglobulin fusion proteins, US Patent 5225538, 1993; Lasky, L. A., Rosen, S. D., Stachel, S. E., Singer, M. S., and Yednock, T. A., Lymphocyte homing receptors 1993, US Patent 5216131, 1993; Hession, C. A., Lobb, R. R., Goelz, S. E., Osborn, L., Benjamin, C. D., and Rosa, M. D., DNA sequences encoding vascular cell adhesion molecules (VCAMS), US Patent 5272263, 1993.
111. Capon, D. J. and Lasky, L. A., Hybrid immunoglobulins, US Patent 5116964, 1992; Lymphocyte homing receptor/immunoglobulin fusion proteins, US Patent 5225538, 1993; Lasky, L. A., Rosen, S. D., Stachel, S. E., Singer, M. S., and Yednock, T. A., Lymphocyte homing receptors 1993, US Patent 5216131, 1993; Hession, C. A., Lobb, R. R., Goelz, S. E., Osborn, L., Benjamin, C. D., and Rosa, M. D., DNA sequences encoding vascular cell adhesion molecules (VCAMS), US Patent 5272263, 1993.
112. Capon, D. J. and Lasky, L. A., Hybrid immunoglobulins, US Patent 5116964, 1992; Lymphocyte homing receptor/immunoglobulin fusion proteins, US Patent 5225538, 1993; Lasky, L. A., Rosen, S. D., Stachel, S. E., Singer, M. S., and Yednock, T. A., Lymphocyte homing receptors 1993, US Patent 5216131, 1993; Hession, C. A., Lobb, R. R., Goelz, S. E., Osborn, L., Benjamin, C. D., and Rosa, M. D., DNA sequences encoding vascular cell adhesion molecules (VCAMS), US Patent 5272263, 1993.
113. Capon, D. J. and Lasky, L. A., Hybrid immunoglobulins, US Patent 5116964, 1992; Lymphocyte homing receptor/immunoglobulin fusion proteins, US Patent 5225538, 1993; Lasky, L. A., Rosen, S. D., Stachel, S. E., Singer, M. S., and Yednock, T. A., Lymphocyte homing receptors 1993, US Patent 5216131, 1993; Hession, C. A., Lobb, R. R., Goelz, S. E., Osborn, L., Benjamin, C. D., and Rosa, M. D., DNA sequences encoding vascular cell adhesion molecules (VCAMS), US Patent 5272263, 1993.
114. Weissleder, R. and Papisov, M. I., Pharmaceutical iron oxides for MR imaging, Rev. Magn. Res. Med., 4, 1, 1992.
115. Shen, T., Weissleder, R., Papisov, M. I., Bogdanov, A. A., and Brady, T. J., Monocrystalline iron oxide nanocompounds (MION): Physico-chemical properties, J. Magn. Res. Imag., 29, 599, 1993.
116. Weissleder, R., Stark, D. D., Engelstad, B. L., Bacon, B. R., Compton, C. C., White, D. L., Jacobs, P., and Lewis, J., Superparamagnetic iron oxide: pharmacokinetics and toxicity, Am. J. Radiol., 152, 167, 1989.
117. Papisov, M. I., Savelyev, V. Y., Sergienko, V. B., and Torchilin, V. P., Magnetic drug targeting, I. In vivo kinetics of radiolabelled magnetic drug carriers, Int. J. Pharm., 40, 201, 1987.
118. Papisov, M. I., Bogdanov, A. A., Schaffer, B.S., Nossiff, N., Shen. T., Weissleder, R., and Brady, T. J., Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution, J. Magn. & Magn. Mater., 122, 383, 1993.
119. Weissleder, R., Heautot J.-F., Schaeffer, B. K., Bogdanov, A., Papisov, M., and Brady, T. J., A high efficiency lymphotropic agent for MR lymphography, Radiology, 191, 225, 1994.
120. Papisov, M. I., Schaffer, B. S., Nossiff, N., Bogdanov, A. A., Weissleder, R., and Brady, T. J., Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution, in Proceedings of Sixth International Conference on Magnetic Fluids, Paris, France, Ministére de la Recherche et de la Technologie, Paris, 1992, 182.
121. Bogdanov, Jr., A., Papisov, M., Weissleder, R., Shen, T., and Brady, T. J., Opsonization of dextran-stabilized iron oxides with plasma proteins, in Abstracts of 11th Meeting of the Soc. of Magnetic Resonance in Medicine, SMRM, Berkeley, CA, 864, 1994.
122. Law, S.-K., Minich T. M., and Levine R. P., Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups, Biochemistry, 23, 3267, 1984.
123. Law, S.-K., Lichtenberg, N. A., and Levine, R. P., Covalent binding and hemolitic activity of complement proteins, PNAS, 77, 7194, 1980.
124. Pagburn, M. K., Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides, J. Immunol., 142, 2759, 1989.
125. Papisov, M. I., Weissleder, R., and Brady, T. J., Systemic lymph node targeting with macromolecular imaging agents, in Handbook of targeted delivery of imaging agents, Torchilin, V. P., Ed., CRC Press, Boca Raton, FL, 385, 1995.
126. Papisov, M. I., Weissleder, R., Schaffer, B. K., Tsai, E., Bogdanov, Jr., A. A., Nossiff, N., Bogdanova, A. V., and Brady, T. J., Lymphotropic contrast agents: in vivo transfer processes, in Proceedings of the Society of Magnetic Resonance in Medicine, Twelfth Annual Scientific meeting, SMRM, Berkeley, CA, 499, 1993.
127. Papisov, M. I., Bogdanov, Jr., A. A., Weissleder, R., Tsai, E., Schaffer, B. S., Molea, N., Bogdanova, A. V., Strauss, H. W., and Brady, T. J., Intravenous contrast agents targeted to lymphatic tissue, in Proceedings of Eleventh Annual Meeting of the Society of Magnetic Resonance in Medicine, SMRM, Berkeley, CA, 567, 1992.
128. Papisov, M. I., Poss, K., Weissleder, R., and Brady, T. J., Intravenous lymphotropic polymers: the SPAR effect, in Proceedings of Second Meeting of the Soc. of Magnetic Resonance, SMRM, Berkeley, CA, 388, 1994.
129. Papisov, M. I., Weissleder, R., Bogdanov, Jr., A. A., and Brady, T. J., Intravenous lymph node-targeted carriers, in Proceedings of 21st International Symposium on Controlled Release of Bioactive Materials, Controlled Release Soc. Inc., Deerfield, IL, 152, 1994.
130. Torchilin, V. P. and Papisov, M. I., Why do PEG-coated liposomes circulate long? J. Lipos. Res., 4, 725, 1994.
131. Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, Jr., A. A., Trubetskoy, V. S., Herron, J. N., and Gentry, C. A., Poly(ethyleneglycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, BBA, 1195, 11, 1994.
132. Papisov, M. I., Martin, C., Poss, K., Weissleder, R., and Brady, T. J., Amplification of steric effects in cooperative systems, in Proceedings of 22nd International Symposium on Controlled Release of Bioactive Materials, Controlled Release Society, Inc., Deerfield, IL, 442, 1995.
133. Bradfield, J. W. B., The new look at reticuloendothelial blokade, Br. J. Exp. Pathol., 61, 617, 1980.
134. Molea, N., Callahan, R., Wilkinson, R., Tsai, E., Brady, T. J., Strauss, H. W., and Papisov, M. I., Biodistribution and imaging studies of a new radiopharmaceutical for lymph node imaging following intravenous administration, Eur. J. Nucl. Med., 19, 590, 1992.
135. Poss, K., Bogdanova, A. V., Weissleder, R., Brady, T. J., and Papisov, M. I., Cytotoxicity of doxorubicin covalently linked with the backbone of lymphotropic graft copolymers, in Seventh international symposium on recent advances in drug delivery systems, Abstracts, University of Utah, 173, 1995.
136. Takakura, Y., Fudjita, T., Hashida, M., and Sezaki, H., Disposition characteristics of macromolecules in tumor-bearing mice, Pharm. Res., 7, 339, 1990.
137. Papisov, M. I., Modeling in vivo transfer of long-circulating polymers (two classes of long-circulating polymers and factors affecting their transfer m vivo), Adv. Drug Del. Rev., 16, 127, 1995.
138. Ross, G. D., Cain, J. A., and Lachmann, P. J., Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymozan and rabbit erythrocytes as well as a receptor for iC3b, J. Immunol., 134, 3307, 1985.
139. Atkinson, J. P. and Frank, M. M., Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man, J. Clin. Investigation, 54, 339, 1974.
140. Ljungstrom, K. G., Willman, B., and Hedin, H., Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1, Ann. Fr. Anesth. Reanim., 12, 219, 1993.
141. Benecky, M. J., Kolvenbach, C. G., Wine, R. W., DiOrio, J. P., and Mosesson, M. W., Human plasma fibronectin structure probed by steady-state fluorescence polarization: evidence for a rigid oblate structure, Biochemistry, 29, 3082, 1990.
142. Wolff, C. and Lai, C. S., Fluorescence energy transfer detects changes in fibronectin structure upon surface binding, Arch. Biochem. Biophys., 268, 536, 1989.
143. Walton, K. W., Almond, T. J., Robinson, M., and Scott, D. L., An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes, Br. J. Exp. Path., 65, 191, 1984.
144. Kinoshita, T., Biology of complement: the overture, Immunol. Today, 12, 291, 1991.
145. Sim, R. B. and Reid, K. B. M., C1: molecular interactions with activating systems, Immunol. Today, 12, 307, 1991.
146. Young, N. M. and Leon, M. A., The carbohydrate specificity of conglutinin and its homology to proteins in the hepatic lectin family, BBRC, 143, 645, 1987.
147. Ezefcowitz, R. A. B., Day, L. E., and Herman, G. A., A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins, J. Exp. Med., 167, 1034, 1988.
148. Wright, S. D., Tobias, P. S., Ulevitch, R. J., and Ramos, R. A., Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages, J. Exp. Med., 170, 1231, 1989.
149. Tobias, R S., Soldau, K., Kline, L., Lee, J, D., Kato, K., Martin, T. P., and Ulevitch, R. J., Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein, J. Immunol., 150, 3011, 1993.
150. Savill, J., Dransfield, I., Hogg, N., and Haslett, C., Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis, Nature, 343, 170, 1990.
151. Pinteric, L., Assimeh, S. M., Kells, D. I. C., and Painter, R. H.,The ultrastructure of C1t, a subcomponent of the first component of complement: an EM and ultracentrifuge study, J. Immunol., 117, 79, 1976.
152. Saxena, U., Nagpurkar, A., Dolphin, P. J., and Mookerjea, S., A study on the selective binding of apoprotein B- and E-containing human plasma lipoproteins to immobilized rat serum phosphorilcholine-binding protein, J. Biol. Chem., 262, 3011, 1987.
153. Kottgen, E., Hell, B., Kage, A., and Tauber, R., Lectin specificity and binding characteristics of human C-reactive protein, J. Immunol., 149, 445, 1992.
154. Rice, K. G. and Lee, Y. C., Modification of triantennary glycopeptide into probes for the asialoglycoprotein of hepatocytes, J. Biol. Chem., 265, 18423, 1990.
155. Haltiwanger, R. S., Lehrman, M. A., Eckardt, A. E., and Hill, R. L., The distribution and localization of the Fucose-binding lectin in rat tissues and the identification of a high affinity form of mannose/N-acetylglucosamine-binding lectin in rat liver, J. Biol. Chem., 261, 7433, 1986.
156. Rohrer, L., Freeman, M., Kodama, T., Penman, M., and Krieger, M., Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II, Nature 343, 570, 1990.
157. Bogdanov, Jr., A. A., Weissleder, R., Frank, H. W., Bogdanova, A. V., Nossiff, N., Schaeffer, B. K., Tsai, E., Papisov, M. I., and Brady, T. J., A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies, Radiology, 187, 701, 1993.